Literature DB >> 35174345

Metabolomics reveals potential plateau adaptability by regulating inflammatory response and oxidative stress-related metabolism and energy metabolism pathways in yak.

Meizhou Huang1,2, Xin Zhang1, Wenjun Yan3, Jingjing Liu1, Hui Wang1.   

Abstract

Species are facing strong selection pressures to adapt to inhospitable high-altitude environments. Yaks are a valuable species and an iconic symbol of the Qinghai-Tibet Plateau. Extensive studies of high-altitude adaptation have been conducted, but few have focused on metabolism. In the present study, we determined the differences in the serum metabolomics between yaks and the closely related species of low-altitude yellow cattle and dairy cows. We generated high-quality metabolite profiling data for 36 samples derived from the three species, and a clear separation trend was obtained between yaks and the other animals from principal component analysis. In addition, we identified a total of 63 differentially expressed metabolites among the three species. Functional analysis revealed that differentially expressed metabolites were related to the innate immune activation, oxidative stress-related metabolism, and energy metabolism in yaks, which indicates the important roles of metabolites in high-altitude adaptation in yaks. The results provide new insights into the mechanism of adaptation or acclimatization to high-altitude environments in yaks and hypoxia-related diseases in humans. © Copyright 2022 Korean Society of Animal Science and Technology.

Entities:  

Keywords:  Cattle; Dairy cow; High-altitude adaptation; Metabolomics; Yak

Year:  2022        PMID: 35174345      PMCID: PMC8819316          DOI: 10.5187/jast.2021.e129

Source DB:  PubMed          Journal:  J Anim Sci Technol        ISSN: 2055-0391


INTRODUCTION

The Qinghai-Tibetan Plateau (QTP), characterized by low temperature and hypobaric hypoxia, is the highest plateau in the world, with an average altitude > 4,000 m above sea level. Species are facing strong selection pressure to adapt to inhospitable high-altitude environments [1]. The yak (Bos grunniens) is an important domesticated ruminant. It is the only large mammal inhabiting the QTP and is an iconic symbol of the QTP [2]. Yaks living at high altitudes more than 7,000 years, and must adapt to the stress of decreased oxygen availability [3]. Yaks have numerous special morphological and physiological mechanisms for life at high altitudes, e.g., blunted hypoxic pulmonary vasoconstriction [4], increased foraging ability [5], enhanced glucose uptake and aerobic respiration [6], and improved bioenergy metabolism than mammals living in the plains [7]. Genome analysis identified an expansion in yak of gene families related to sensory perception and energy metabolism comparied with cattle [8], and differentially expressed miRNAs have also been found to be enriched in hypoxia-related pathways [9]. In addition, to reduce the risk of infection and disease, the activation of innate immunity was higher in yaks than in other cattle [10]. These findings partially reveal the adaptive mechanisms of yaks due to natural selection in a high-altitude and hypoxic environment, but few investigations have focused on the role of metabolites. High-altitude hypoxia continuously affects the physical performance of people and animals [11]. Survival in high-altitude hypoxia requires a profound adaptive shift in metabolic processes [12]. In addition, hypoxia is related to homeostasis and the metabolic rate in adult tissues [13]. Organic metabolites are the reactants, intermediates or products of enzymatic reactions and represent the final products of cellular processes. The trend of contemporary scientific development is to follow systems biology. Investigation into the metabolome in response to genetic modification or physiological stimulus is a part of systems biology [14]. Identifying metabolic pathways has the potential to improve the understanding of physiological mechanisms [15]. The metabolome can reveal total metabolic profile changes in biological phenotypes and silent phenotypes [16]. In this study, the serum metabolites of yaks (B. grunniens), yellow cattle (Bos taurus) and China Holstein dairy cows (Bos taurus) were analyzed using a nontargeted metabolomics approach based on ultra-performance liquid chromatography-quadrupole time-of-flight mass spectrometry (UPLC-Q-TOF-MS). Comparing yaks, yellow cattle and China Holstein dairy cows may contribute to understanding evolutionary adaptation and provide meaningful data for survival at high altitudes.

MATERIALS AND METHODS

Sample collection

Blood samples were collected between 9:00 and 10:00 am by jugular venous puncture using vacuum tubes from 12 white yaks (Qilian Township, 37°41’6”N, 102°26’24”E, altitude: 3,600 m), 12 local yellow cattle (Tanshanling Town, 37°4’38”N, 102°24’14”E, altitude: 2,200 m), and 12 China Holstein dairy cows (Anyuan Town, 37°8’24”N, 102°37’48”E, altitude: 1,700 m) in Tianzhu County on the edge of QTP, Gansu Province, China (Fig. 1). After the blood was left to stand for 30 min, it was centrifuged at 1,000 ×g for 5 min at 4°C. Then, the serum was extracted, immediately frozen in liquid nitrogen and stored until analysis was carried out. All animals are female, and about three years old. Yaks and yellow cattle graze the natural grassland throughout the year without supplementary feed and housing. Holstein dairy cows (milk production: 27.1 ± 0.85 kg/day, parity: 2, days in milk [DIM]: 91.6 ± 7.5 days) were fed the total mixed rations (TMR) diets ad libitum, the basal diet was formulated based on the Feeding Standards of Dairy Cattle in China. The three species had similar physical characteristics, and the characteristics enrolled yak, cattle, and Holstein dairy cows are shown in Table 1. The three pasture sites are traditionally used by local herders for grazing, with similar environment and climatic conditions (temperature: 19.2 ± 1.1°C, relative humidity: 65.0 ± 2.2%), except altitude. In order to minimize the controlling variables of feeding and environmental factors among the three species, the blood was collected in August, 2021. The animal experiment was approved, and the animals received humane care according to the Ethical Committee rules of Lanzhou University (RIB21110301).
Fig. 1.

The geographic distribution of the sampling locations for white yak, yellow cattle and dairy cow on the edge of Qinghai-Tibetan Plateau, China.

Table 1.

The characteristics of enrolled yak, cattle, and Holstein dairy cows

GroupBody condition scoreParityAge (y)Milk production (kg/d)Days in milk (d)
Yak3.5 ± 0.423-89.6 ± 10.5
Cattle3.3 ± 0.523-87.5 ± 9.6
Holstein dairy cows3.2 ± 0.32327.1 ± 0.8591.6 ± 7.5

Metabolite extraction

The collected samples were thawed at 4°C, and 100 μL of sample was mixed with 400 μL of precooled methanol/acetonitrile (1:1, v/v). It was incubated at room temperature for 10 min and then centrifuged. The supernatants were collected, dried, and then resuspended in 30 μL water/acetonitrile (98:2, v/v) for MS analysis.

Liquid chromatography conditions

First, a UPLC system (SCIEX, Framingham, MA, USA) was used for chromatographic separations. Reversed-phase separation was performed using an ACQUITY UPLC T3 column. Solvent A (ultrapure water, 0.1% formic acid) and solvent B (acetonitrile, 0.1% formic acid) comprised the mobile phase.

Quadrupole time-of-flight mass spectrometry conditions

The metabolites were detected using a tandem mass spectrometer (TripleTOF5600plus, SCIEX). The details of the Q-TOF mass spectrometry conditions were based on our previous publication [17].

Processing of metabolomics data

LC−MS raw data files were processed by the CAMERA and XCMS packages of R software. Retention time (RT) and m/z data were used to identify each ion. The metabolites were annotated using the human metabolome database (HMDB) database and Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis. MetaX was used to further preprocess the intensity of the peak data. The “50% rule” was applied to remove the systematic bias or technical variation by normalizing the data according to our previous publication [17], and the results showed a normal distribution after normalization processing. Outlier detection and batch effects were evaluated by principal component analysis (PCA). False discovery rate (FDR) and supervised partial least squares-discriminant analysis (PLS-DA) were conducted to adjust the p value. The important features were selected based on a variable importance in the projection (VIP) cutoff value of 1.0.

Determination of inflammatory cytokines and antioxidant enzymes

The levels of interleukin-2 (IL-2), interleukin-6 (IL-6) and tumor necrosis factor-α (TNF-α) in serum were determined using ELISA kits. The levels of malondialdehyde (MDA), total antioxidant capacity (T-AOC), and glutathione peroxidase (GSH-Px) in serum were measured by chemical colorimetry. All kits were purchased from Nanjing Jiancheng Bioengineering Institute (Nanjing, China). The detailed principles and methods for the detection of MDA, T-AOC and GSH-Px have been described in our previous publication [18].

Statistical analysis

GraphPad Prism 9 was employed to perform statistical analyses by single factor analysis of variance (one-way ANOVA). P values less than 0.05 indicated a significant difference.

RESULTS

Serum metabolite analysis

Box plots were used to analyze the identified serum metabolites in yaks, yellow cattle and dairy cows. All samples showed a similar range of metabolite levels (Fig. 2A). Serum metabolomic analysis was used to determine whether the metabolic profiles of yaks are separable from those of dairy cows and yellow cattle, we used PCA for visualization. Based on the serum metabolic profiles, the score plots of the PCA model discriminating yaks, dairy cows and yellow cattle are presented in Figs. 2B and C. PCA showed that the positive mode of the total variance data was 41.23%, represented by the first two principal components (Fig. 2A), and the negative mode was 52.17% (Fig. 2B). The plot revealed that the serum metabolic profiles of yellow cattle were closely related to those of dairy cows and were not obviously changed. However, the profiles of yaks showed a clear separation trend from those of and yellow cattle and dairy cows.
Fig. 2.

Comparison of distribution of serum metabolite levels among yak, dairy cow and yellow cattle.

(A) Box plots represent the distribution of metabolite peak intensity measurements from serum samples across all subjects. PCA scores plots of serum metabolomic profiles derived from UPLC-Q-TOF-MS spectra showing separation between yak and yellow cattle and dairy cow in the positive mode (B) and negative mode (C). PC, principal component; PCA, principal component analysis; UPLC-Q-TOF-MS, ultra-performance liquid chromatography-quadrupole time-of-flight mass spectrometry.

Comparison of distribution of serum metabolite levels among yak, dairy cow and yellow cattle.

(A) Box plots represent the distribution of metabolite peak intensity measurements from serum samples across all subjects. PCA scores plots of serum metabolomic profiles derived from UPLC-Q-TOF-MS spectra showing separation between yak and yellow cattle and dairy cow in the positive mode (B) and negative mode (C). PC, principal component; PCA, principal component analysis; UPLC-Q-TOF-MS, ultra-performance liquid chromatography-quadrupole time-of-flight mass spectrometry.

Identification of differentially expressed serum metabolites among yaks, yellow cattle and dairy cows

From the 1,815 detected metabolites, we investigated 63 differentially expressed metabolites (Table 2), including L-glutamine, L-glutamic acid, α-linolenic acid, tauroursodeoxycholic acid, and LysoPC (ratio ≥ 5.0 or ≤ 0.2, p < 0.01 and VIP ≥ 1). The relative concentrations of 23 metabolites were significantly higher, while 30 were significantly lower in yaks than in yellow cattle (Table 2). The relative concentrations of 11 metabolites were significantly higher and 15 were significantly lower in yaks than in dairy cows. The relative concentrations of 11 metabolites were significantly lower in yellow cattle than in dairy cows. These metabolites were carbohydrates, amino acids, lipids and their metabolites, suggesting that these metabolic pathways were different among yaks, yellow cattle, and dairy cows. Furthermore, metabolic pathways were significantly different between yaks and yellow cattle and between yaks and dairy cows, but there were similarities between yellow cattle and dairy cows based on the very few differential metabolic profiles (Table 2).
Table 2.

List of serum differential metabolites among yak, yellow cattle and dairy cow (n = 12)

NO.MetabolitesYak vs cattleYak vs dairy cowCattle vs dairy cow
Ratiop-valueVIPRatiop-valueVIPRatiop-valueVIP
1L-Acetopine9.2871.17E-032.2375.1834.55E-032.082
2LysoPC (18:0)7.2117.94E-062.5587.6213.30E-062.906
37-Ketodeoxycholic acid6.7802.93E-032.3580.1615.11E-043.567
4LysoPC (16:0)6.3791.09E-042.3110.1316.89E-062.572
5LysoPC (18:1)6.2193.65E-052.4015.9793.69E-052.539
6Ganoderol A6.0421.81E-052.5645.1104.73E-052.264
7α-Linolenic acid0.1791.93E-052.3420.1811.73E-072.816
8Stearoylcarnitine0.1414.00E-132.7820.1037.26E-143.428
9Taurocholic acid0.0995.33E-063.1510.1867.83E-052.477
10TG (14:0)0.0984.37E-082.9790.0818.98E-101.936
11Heme O0.0893.83E-073.3450.0811.98E-073.623
12Tauroursodeoxycholic acid0.0843.71E-063.3930.1332.61E-053.119
13Ganodermic acid TQ0.0633.96E-073.5000.1472.16E-052.721
14L-Glutamine41.3312.93E-102.09450.7383.27E-092.243
15L-Glutamic acid15.6151.84E-071.76416.3283.30E-062.096
16Daucic acid8.2962.66E-051.4106.9065.44E-051.351
17L-Malic acid5.6352.69E-091.3208.9201.45E-081.798
18Pterosin N0.0951.69E-061.4740.0735.82E-171.882
19Linoleic acid0.0782.03E-061.7440.0602.18E-061.826
20Pyrocatechol sulfate0.0319.83E-112.1300.1061.62E-041.167
21Methyl levulinate0.0072.59E-172.5780.0193.04E-051.582
22LysoPC (22:6)8.0401.68E-093.084
23Lactapiperanol D7.6641.46E-083.178
24Octadecyl fumarate6.9291.33E-072.797
2527-Norcholestanehexol6.2251.89E-073.014
26Lysyl-Threonine5.7564.46E-072.940
275-Hydroxy-tryptophol5.6821.08E-052.663
28LysoPC (22:4)5.6654.70E-082.611
29beta-Elemonic acid5.5551.21E-072.704
30L-Carnitine5.5397.49E-082.715
31Malonyl-Carnitin5.4611.78E-072.920
32Cortisol5.2102.99E-052.455
33Polyporusterone B5.0581.78E-052.896
34Acetaminophen glucuronide0.1995.80E-032.147
35Eicosatetraenoic acid0.1954.34E-062.348
3612-Ketodeoxycholic acid0.1911.81E-042.932
37Pterosin O0.1494.72E-062.921
38Phenylalanyl-Tryptophan0.1449.62E-082.968
39N-Heptanoylglycine0.1371.79E-092.834
40Hexaethylene glycol0.1254.52E-042.333
41Glycyrrhizin0.1071.10E-063.200
42Campesteryl linoleate0.1031.07E-043.643
43Psychosine sulfate0.0911.75E-093.191
44D-Xylose0.0843.42E-032.262
45Cellulose triacetate0.0762.61E-063.463
466a-Hydroxy-paclitaxel0.0706.90E-133.368
47TG (18:1)0.0637.34E-103.311
48Paradol0.0532.32E-153.789
49Torvonin A5.9591.10E-101.534
50Allantoin0.1682.66E-041.632
51Ethyl pyruvate0.1548.04E-051.661
522-Hydroxybutyric acid0.1485.76E-071.539
53Galactitol0.0788.58E-041.423
54Cystathionine ketimine9.3932.68E-041.256
55L-Phenylalanine5.2201.86E-081.467
56PC (16:0)7.8168.68E-032.112
57LysoPC (20:3)0.1964.88E-052.219
58TG (15:0)0.0144.52E-184.6110.1399.69E-052.035
59Heliantriol A10.1831.00E-031.682
60Corbisterol0.1834.19E-065.027
61Diacetoxypropyl stearate0.1769.65E-044.455
62Famprofazone0.1644.15E-075.073
63Leontogenin0.1472.01E-065.420

The ratio is > 5.0 or < 0.2.

LysoPC, lysophosphatidylcholine; TG, triglycerides.

The ratio is > 5.0 or < 0.2. LysoPC, lysophosphatidylcholine; TG, triglycerides.

Metabolic Kyoto encyclopedia of genes and genomes pathway analysis

KEGG analysis was used to predict metabolic pathways for all differential metabolites. Fig. 3 shows the functional enrichment of the top 5 different pathways. The most enriched functional pathways among yak, yellow cattle and dairy cow belonged to metabolic pathways: amino acid metabolism (e.g., phenylalanine, arginine, proline, glycine, valine, leucine, isoleucine and glutamine), phospholipid metabolism (lysophosphatidylcholines [LysoPCs]), and fatty acid metabolism (arachidonic acid metabolism, α-linolenic acid and linolenic acid metabolism).
Fig. 3.

The top 5 different pathways for differential metabolites (up and down) among yak, yellow cattle, and dairy cow in positive (A) and negative (B) ion modes.

Inflammatory cytokines and antioxidant levels

The levels of the inflammatory cytokines IL-2, IL-6, and TNF-α in yak serum were significantly higher than those in yellow cattle and dairy cows (p < 0.05 or p < 0.01) (Figs. 4A, B and C). Oxidative stress is an imbalance of reactive oxygen species (ROS) generation and elimination. High altitude-associated hypobaric hypoxia stress induces ROS production [19]. To determine if the elevated peripheral inflammatory cytokines were accompanied by reactive oxygen production or oxidative damcage [20], serum levels of MDA, T-AOC and GSH-Px were measured by chemical colorimetry. The results showed that there was no significant differences in MDA, T-AOC and GSH-Px levels among yaks, yellow cattle and dairy cows (p > 0.05) (Figs. 4D, E, and F).
Fig. 4.

The inflammatory cytokines of IL-2 (A), IL-6 (B), and TNF-α (C) were determined using ELISA kits, and MDA level (D), T-AOC (E) and GSH-Px activity (F) related to antioxidant defense system in serum were measured by chemical colorimetry.

*p < 0.05, **p < 0.01. IL, interleukin; TNF, tumor necrosis factor; MDA, malondialdehyde; T-AOC, total antioxidant capacity; GSH-Px, glutathione peroxidase.

The inflammatory cytokines of IL-2 (A), IL-6 (B), and TNF-α (C) were determined using ELISA kits, and MDA level (D), T-AOC (E) and GSH-Px activity (F) related to antioxidant defense system in serum were measured by chemical colorimetry.

*p < 0.05, **p < 0.01. IL, interleukin; TNF, tumor necrosis factor; MDA, malondialdehyde; T-AOC, total antioxidant capacity; GSH-Px, glutathione peroxidase.

DISCUSSION

Yaks are an iconic symbol of QTP and can be used as a model to elucidate the mechanisms of hypoxia adaptation. The three specises of yak, yellow cattle and Holstein dairy cow belong to subtribe Bovina [21]. Holstein and yellow cattle should be probably separated from yak about 4.4 to 5.3 million years ago [10,22]. Systems biology is the trend of contemporary scientific development [23]. Comparative transcriptome sequencing revealed that the innate immunity were more activated in yak lung than low-altitude cattle (Sanjiang and Holstein cattle) [10,24]. Proteomics of skeletal muscle mitochondria showed that the significantly affected pathway in yaks and cattle was oxidative phosphorylation [7]. Identification of metabolic pathways using metabolomics comparisons between closely related species has the potential to provide insights into the basis of mammalian divergence and adaptation. To understand differences in the global metabolic profiles and relevant metabolic pathways of yaks, yellow cattle and dairy cows during acclimatization to high altitude, we utilized UPLC-Q-TOF-MS to determine the serum metabolite profiles of the three breeds. We detected a clear separation trend between yaks and yellow cattle and dairy cows. A total of 63 different metabolites were obtained in serum. An integrative view plot of the metabolic changes among white yaks, yellow cattle and dairy cows was prepared (Fig. 3). The major perturbed metabolic patterns and plausible pathways are involved in amino acid metabolism, phospholipid metabolism, and fatty acid metabolism, which are associated with hypobaric hypoxia.

Amino acid metabolism

Glutamine is a key metabolite in the alanine, aspartate and glutamate metabolism pathways [25]. A previous study reported that high-altitude exposure leads to lower glutamate levels due to decreased activity of glutamine synthetase [26]. In contrast, we found significantly elevated levels of glutamic acid and glucogenic amino acids that produce pyruvic acid, α-ketoglutaric acid, and oxaloacetic acid in the serum of yaks in comparison with yellow cattle and dairy cows [27] (Table 2). The results of this study indicate that yaks have the highest levels of protein catabolism and amino acid mobilization. Therefore, the mobilization of yak muscle protein may be a metabolic adaptation to hypobaric hypoxia. Pathway analysis also showed improved energy metabolism and promoted acclimatization to high altitude by increasing the metabolism of phenylalanine, arginine, proline and glutamine to meet the energy requirements in yaks (Fig. 3). This result is consistent with the previous finding that hypobaric hypoxia exposure can enhance glucose and amino acid metabolism [28].

Phospholipid metabolism

Phospholipids play a role as a cellular bilayer with membrane proteins, and they are involved in the maintenance of hepatic lipid metabolism [29]. Our results show that almost all LysoPCs, including LysoPC (18:0), LysoPC (16:0), LysoPC (18:1), LysoPC (22:6) and LysoPC (22:4), were markedly increased in yaks compared with yellow cattle and dairy cows (Table 2). LysoPCs participate in the inflammatory response by mediating cell signaling pathways in monocytes and macrophages [30,31]. To verify the increased LysoPCs, the serum levels of cytokines IL-2, IL-6, and TNF-α were detected. The results showed that the levels of IL-2, IL-6, and TNF-α were significantly higher in yaks than in cattle and dairy cows (Figs. 4A, B, and C), which is consistent with the increased LysoPCs. Environmental factors such as hypobaric hypoxia, cold and UV exposure at high altitude can suppress the immune system [32]. Tumor necrosis factors and interleukins can mediate innate immunity signaling. Xin et al. [10] reported that the immune system was more activated and the genes related to immune were up-regulated in yak compared with Sanjiang and Holstein cattle [10]. A significant elevation of LysoPCs and cytokines (IL-2, IL-6, and TNF-α) might be responsible for yaks being more tolerant to hypoxia at high altitudes than yellow cattle and dairy cows by activating innate immunity system.

Fatty acids metabolism

Hypoxia is associated with an increase in the generation of reactive oxygen species (ROS), and an excessive load of ROS generated may result in cell injury and dysfunction [33]. Excessive ROS can lead to lipid peroxidation, MDA can reflect the level of lipid peroxidation. ROS are balanced by natural antioxidant compounds such as GSH-Px, superoxide dismutase (SOD) and catalase (CAT) [34]. We found that serum MDA levels, T-AOC and GSH-Px activity were not significantly changed in yak in comparison with yellow cattle and Holstein dairy cows (Figs. 4D, E, and F), based on they had similar physical characteristics (Table 1). The results demonstrate that yaks adapt to hypoxia-induced oxidative stress at high altitudes do not by increasing antioxidant enzyme levels. Free fatty acids (FFAs) are risk factors for cardiovascular diseases and are closely related to metabolic syndromes [35]. FFAs are significant sources of ROS [36], mainly through the activation of NADPH oxidase [37]. There was a dose-dependent increase in ROS in monocytes exposed to FFAs [38]. Polyunsaturated fatty acids (PUFAs) are a favorable target for ROS [39]. Oxidative breakdown of PUFAs may affect lipid metabolism and the expression of genes and proteins related to cell differentiation [40]. α-Linolenic acid and linoleic acid are PUFAs. Linoleic acid contains unsaturated double bonds that are highly vulnerable to ROS [41], and has been linked to red blood cell damage by promoting redox reactions [42]. The ROS production was greater in bovine mammary epithelia cells treated with linoleic acid and α-linolenic acid [43]. Arachidonic acid has been demonstrated to promote inflammatory responses by activating the mitogen-activated protein kinase (MAPK) and c-Jun N-terminal kinases (JNK) pathways by increasing TNF-α levels [44,45]. Arachidonic acid-derived metabolites also can propagate inflammation and oxidative stress [46]. Arachidonic acid suppressed the cell growth of hepatic cells by dose‐dependently inducing the production of ROS [47]. In the present work, FFAs (α-linolenic acid, linoleic acid and arachidonic acid) were significantly decreased in yaks compared with yellow cattle and Holstein dairy cows (Table 2). We speculate that yaks can decrease the level of FFAs (α-linolenic acid, linoleic acid and arachidonic acid) in serum induced by hypoxia and that the decreased FFAs can attenuate cell injury and hypoxia dysfunction by inhibiting oxidative stress.

CONCLUSION

A clear separation trend between the serum metabolic profiles of yaks and yellow cattle and dairy cows was demonstrated by PCA. In addition, a total of 63 differentially expressed metabolites were identified among the three species. Functional analysis revealed that differentially expressed metabolites were related to the innate immune activation (elevation of LysoPCs and cytokines), oxidative stress-related metabolism (arachidonic acid metabolism, α-linolenic acid metabolism, and linoleic acid metabolism) and energy metabolism (fatty acid metabolism and amino acid metabolism) in yaks, which indicates the important roles of metabolites in high-altitude adaptation in yaks.
  46 in total

Review 1.  Systems level studies of mammalian metabolomes: the roles of mass spectrometry and nuclear magnetic resonance spectroscopy.

Authors:  Warwick B Dunn; David I Broadhurst; Helen J Atherton; Royston Goodacre; Julian L Griffin
Journal:  Chem Soc Rev       Date:  2010-08-17       Impact factor: 54.564

2.  Evolution and domestication of the Bovini species.

Authors:  K Zhang; J A Lenstra; S Zhang; W Liu; J Liu
Journal:  Anim Genet       Date:  2020-07-27       Impact factor: 3.169

3.  Disruption of group IVA cytosolic phospholipase A(2) attenuates myocardial ischemia-reperfusion injury partly through inhibition of TNF-α-mediated pathway.

Authors:  Yukio Saito; Kazuhiro Watanabe; Daisuke Fujioka; Takamitsu Nakamura; Jun-ei Obata; Kenichi Kawabata; Yosuke Watanabe; Hideto Mishina; Shun Tamaru; Yoshihiro Kita; Takao Shimizu; Kiyotaka Kugiyama
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-03-16       Impact factor: 4.733

4.  Analysis of plasma metabolic profiling and evaluation of the effect of the intake of Angelica keiskei using metabolomics and lipidomics.

Authors:  Hyun-A Oh; Hyunbeom Lee; Soo-Yeon Park; Yeni Lim; Oran Kwon; Ji Yeon Kim; Donghak Kim; Byung Hwa Jung
Journal:  J Ethnopharmacol       Date:  2019-07-05       Impact factor: 4.360

5.  Elevated concentrations of nonesterified fatty acids increase monocyte expression of CD11b and adhesion to endothelial cells.

Authors:  Wei-Yang Zhang; Eric Schwartz; Yingjie Wang; Jeanne Attrep; Zhi Li; Peter Reaven
Journal:  Arterioscler Thromb Vasc Biol       Date:  2005-12-15       Impact factor: 8.311

6.  The yak genome and adaptation to life at high altitude.

Authors:  Qiang Qiu; Guojie Zhang; Tao Ma; Wubin Qian; Junyi Wang; Zhiqiang Ye; Changchang Cao; Quanjun Hu; Jaebum Kim; Denis M Larkin; Loretta Auvil; Boris Capitanu; Jian Ma; Harris A Lewin; Xiaoju Qian; Yongshan Lang; Ran Zhou; Lizhong Wang; Kun Wang; Jinquan Xia; Shengguang Liao; Shengkai Pan; Xu Lu; Haolong Hou; Yan Wang; Xuetao Zang; Ye Yin; Hui Ma; Jian Zhang; Zhaofeng Wang; Yingmei Zhang; Dawei Zhang; Takahiro Yonezawa; Masami Hasegawa; Yang Zhong; Wenbin Liu; Yan Zhang; Zhiyong Huang; Shengxiang Zhang; Ruijun Long; Huanming Yang; Jian Wang; Johannes A Lenstra; David N Cooper; Yi Wu; Jun Wang; Peng Shi; Jian Wang; Jianquan Liu
Journal:  Nat Genet       Date:  2012-07-01       Impact factor: 38.330

Review 7.  Hypoxia-related lipid peroxidation: evidences, implications and approaches.

Authors:  Claus Behn; Oscar F Araneda; Aníbal J Llanos; Gloria Celedón; Gustavo González
Journal:  Respir Physiol Neurobiol       Date:  2007-06-14       Impact factor: 1.931

Review 8.  Evolutionary adaptation to high altitude: a view from in utero.

Authors:  Colleen Glyde Julian; Megan J Wilson; Lorna G Moore
Journal:  Am J Hum Biol       Date:  2009 Sep-Oct       Impact factor: 1.937

Review 9.  Obesity and free fatty acids.

Authors:  Guenther Boden
Journal:  Endocrinol Metab Clin North Am       Date:  2008-09       Impact factor: 4.741

10.  Arachidonic acid suppresses hepatic cell growth through ROS-mediated activation of transglutaminase.

Authors:  Xian-Yang Qin; Jun Lu; Muyi Cai; Soichi Kojima
Journal:  FEBS Open Bio       Date:  2018-09-11       Impact factor: 2.693

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.